{"schema_version":"secwatch.filing_event.v1","accession":"0001638833-25-000031","form_type":"8-K","ticker":"SGRY","cik":"0001638833","company_name":"Surgery Partners, Inc.","filed_at":"2025-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.270140+00:00","generated_at":"2026-05-25T17:57:40.671466+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Surgery Partners Q4 revenue up 17.5% to $864.4M; Adj EBITDA +15.1%; sets 2025 guidance","bullets":["Q4 revenue $864.4M (+17.5% YoY); full-year revenue $3.1B (+13.5% YoY).","Q4 adjusted EBITDA $163.8M (+15.1%); full-year $508.2M (+16.0%).","Same-facility revenue growth 5.6% in Q4, 8.0% full year; cases +5.1% and +3.9% respectively.","Net loss attributable $108.5M Q4, $168.1M full year; includes non-cash tax valuation allowance. No federal income taxes expected until 2029.","2025 guidance: revenue $3.30-$3.45B; Adj EBITDA $555-$565M. Liquidity >$770M."],"urls":{"canonical":"https://secwatch.observer/filing/0001638833-25-000031","json":"https://secwatch.observer/filing/0001638833-25-000031.json","markdown":"https://secwatch.observer/filing/0001638833-25-000031.md","text":"https://secwatch.observer/filing/0001638833-25-000031.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1638833/000163883325000031/0001638833-25-000031-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1638833/000163883325000031/sgry-20250303.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T17:57:40.671466+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}